Government ContextGovernment Context
ActivityRulesGrantsPress releasesHearingsBills
ViewsAgenciesTopicsOrganizationsCommitteesLegislators
PricingLog inCreate account
Activity
RulesProposed and final rules open for commentGrantsFederal funding opportunities and deadlinesPress releasesWhat agencies are announcing publiclyHearingsCongressional committee hearings and meetingsBillsLegislation, actions, amendments, and votes
Views
AgenciesEverything from a single federal agencyTopicsActivity grouped by policy areaOrganizationsCompanies, associations, and advocacy groupsCommitteesHouse, Senate, and joint committee activityLegislatorsMembers of Congress, service, bills, and votes
Pricing
LoginCreate account
Organizations › United States Pharmacopeia
US

United States Pharmacopeia

Other/org/united-states-pharmacopeia-usp
Related topics
  • Pharmaceutical Policy
1 event unlock with a free account
1 rulemaking this week
Create free account →
July 2026
Public comment · Jul 8
United States Pharmacopeia (USP) submitted a public comment on General Considerations for the Use of New Approach Methodologies in Drug Development; Guidance for Industry - Draft Guidance
You’re all caught up.

Comment record

Recent public comments attributed to this organization.

  • General Considerations for the Use of New Approach Methodologies in Drug Development; Guidance for Industry - Draft Guidance
    Jul 8Support
Government ContextGovernment Context

Track federal rulemaking documents, topics, and agencies — built on primary sources across the federal government.

ActivityRulesGrantsPress releases
ViewsAgenciesTopicsOrganizations
GuidesInstall Government ContextFive questions to ask your agentAll guides
CompanyAboutData sourcesPricing
LegalPrivacyTerms
© 2026 Government Context. Built on primary government sources.Not affiliated with any U.S. government agency.